Volume 10 (2012): Issue 1 (Jan 2012)

in Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Cover Journal of the National Comprehensive Cancer Network
NCCN News
Pages: xiv–xv
Oncology Research Program
Pages: xxvii–xxviii
Correspondence
By: Robert J. Schulz and A. Robert Kagan
Pages: 1
JNCCN Reaches 10
By: Harold J. Burstein
Pages: 3
JNCCN at 10
By: William T. McGivney
Pages: 4–6
By the Pricking of My Thumbs, Something Wicked This Way Comes: Sporadic Cancers Versus Eponymous Hereditary Cancer Predisposition Syndromes
By: Christos Vaklavas, John R. Ross, Lisle M. Nabell, Andres Forero, Martin J. Heslin, and Tina E. Wood
Pages: 7–13
Value-Based Insurance Design: Aligning Incentives, Benefits, and Evidence in Oncology
By: Jonas A. de Souza, Mark J. Ratain, and A. Mark Fendrick
Pages: 18–23
Malignant Pleural Mesothelioma
By: David S. Ettinger, Wallace Akerley, Hossein Borghaei, Andrew Chang, Richard T. Cheney, Lucian R. Chirieac, Thomas A. D'Amico, Todd L. Demmy, Apar Kishor P. Ganti, Ramaswamy Govindan, Frederic W. Grannis, Leora Horn, Thierry M. Jahan, Mohammad Jahanzeb, Anne Kessinger, Ritsuko Komaki, Feng-Ming (Spring) Kong, Mark G. Kris, Lee M. Krug, Inga T. Lennes, Billy W. Loo, Renato Martins, Janis O'Malley, Raymond U. Osarogiagbon, Gregory A. Otterson, Jyoti D. Patel, Mary Pinder Schenck, Katherine M. Pisters, Karen Reckamp, Gregory J. Riely, Eric Rohren, Scott J. Swanson, Douglas E. Wood, and Stephen C. Yang
Pages: 26–41
Novel Therapies in Phase II and III Trials for Malignant Pleural Mesothelioma
By: Marjorie G. Zauderer and Lee M. Krug
Pages: 42–47
Current Concepts in the Evaluation and Treatment of Patients With Diffuse Malignant Peritoneal Mesothelioma
By: Keli Turner, Sheelu Varghese, and H. Richard Alexander
Pages: 49–57
Chronic Myelogenous Leukemia
By: Susan O'Brien, Camille N. Abboud, Mojtaba Akhtari, Jessica Altman, Ellin Berman, Daniel J. DeAngelo, Steven Devine, Amir T. Fathi, Jason Gotlib, Madan Jagasia, Joseph O. Moore, Javier Pinilla-Ibarz, Jerald P. Radich, Vishnu V.B. Reddy, Neil P. Shah, Paul J. Shami, B. Douglas Smith, David S. Snyder, Meir Wetzler, and Furhan Yunus
Pages: 64–110
How to Choose Frontline Therapy for Chronic Myelogenous Leukemia: So Many Drugs, Not So Many Patients
By: Paul J. Shami
Pages: 112–118
Practical Monitoring of Chronic Myelogenous Leukemia: When to Change Treatment
By: Giuseppe Saglio and Carmen Fava
Pages: 121–129
Health Care Reform and Its Implications for the Academic Cancer Center
By: David C. Hohn
Pages: 130–132
  • Collapse
  • Expand